Amir Hefni is the founder of Resolution Therapeutics. Resolution Therapeutics has raised $84M in total funding. Latest round: Series B.
Amir Hefni is the Chief Executive Officer of Resolution Therapeutics, a clinical-stage biopharmaceutical company focused on developing macrophage therapy for inflammatory and fibrotic diseases. The company recently raised £63.5 million in Series B financing to advance its lead asset, RTX001, into Phase I/II clinical trials for end-stage liver disease.
Full founder directory · Investor directory · Company funding database · Fundraising library